TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma. Reiter FP, Geier A. Lancet 2025 Jan 8:S0140-6736(24)02680-1. doi: 10.1016/S0140-6736(24)02680.

Read + Share

Amedeo Smart

Independent Medical Education

Reiter FP, Geier A. TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma. Lancet 2025 Jan 8:S0140-6736(24)02680-1. doi: 10.1016/S0140-6736(24)02680.
PMID: 39798580